Primordial Origin (Shane)

Submitted by: Shane — Architect of PrimordiaOS, a multi‑realm orchestration system for autonomous and generative AI ecosystems.

1. Support for Competency‑Based Evaluation Framework
I strongly support the FDA’s proposal to evaluate generative‑AI medical
devices through competency assessment rather than static premarket
checklists. Generative AI systems exhibit dynamic behavior, emergent
capabilities, and context‑dependent performance that cannot be adequately
captured through traditional validation methods.

A competency‑based framework should include:

Scenario‑based evaluation using synthetic and real‑world test cases

Stress testing across edge conditions

Repeatable, auditable evaluation pipelines

Lifecycle‑aware competency re‑assessment as models evolve

PrimordiaOS implements these principles through modular “realms” that
allow manufacturers to run controlled competency tests, generate diverse
evaluation scenarios, and maintain deterministic audit trails. This
architecture aligns closely with the FDA’s stated goals.

2. Recommendation: Treat Modular AI Components as Regulatory Units
The discussion paper highlights challenges in regulating systems
composed of multiple interacting AI components. I recommend that the
FDA adopt a modular regulatory abstraction, where discrete functional
units—such as model governance, safety governors, telemetry modules,
and competency evaluators—are treated as identifiable regulatory objects.

This approach:

Enables clearer accountability

Supports component‑level updates without full device recertification
Allows manufacturers to reuse validated modules across devices

Aligns with modern distributed AI architectures

PrimordiaOS uses “realms” as modular, claimable units with deterministic
state transitions. This structure provides a natural mapping to the
regulatory modularity the FDA is considering.

3. Foundation Model Governance: Need for Provenance, Versioning, and
Drift Detection
The FDA correctly identifies foundation models as a major regulatory
challenge. Their scale, adaptability, and broad applicability require
specialized oversight mechanisms.

I recommend that the FDA require:

Model lineage tracking (training data provenance, fine‑tuning history)

Versioned model claiming (immutable identifiers for each model state)

Automated drift detection (monitoring changes in behavior over time)

Governance layers that enforce safety constraints across downstream uses

PrimordiaOS provides these capabilities through multi‑realm governance,
versioned claiming, and autonomous drift‑monitoring agents. These
mechanisms directly support the FDA’s objectives for foundation‑model
oversight.

4. Postmarket Monitoring: Support for Risk‑Tiered Continuous Oversight
I strongly agree with the FDA’s emphasis on risk‑tiered postmarket
monitoring. Generative AI systems require continuous oversight due to their
adaptive nature and potential for performance drift.
A robust postmarket framework should include:

Continuous telemetry collection

Automated anomaly detection

Risk‑tiered monitoring intensity

Transparent reporting pipelines

Lifecycle‑wide safety governance

PrimordiaOS implements continuous multi‑realm telemetry, fault‑tolerant
logging, and autonomous safety agents that detect deviations in model
behavior. These capabilities align with the FDA’s proposed lifecycle
monitoring approach.

5. Recommendation: Encourage Industry Adoption of Lifecycle‑Native
Architectures
The FDA’s discussion paper highlights the need for regulatory approaches
that evolve alongside technology. I recommend encouraging architectures
that are lifecycle‑native—systems designed from the ground up for
competency testing, governance, monitoring, and traceability.

PrimordiaOS is an example of such an architecture, providing:

Built‑in competency evaluation

Foundation‑model governance

Multi‑realm safety oversight

Continuous postmarket telemetry
Deterministic audit trails

These capabilities reduce regulatory burden for manufacturers and improve
patient safety.

Conclusion
The FDA’s discussion paper represents a forward‑looking and highly
constructive foundation for regulating generative AI‑enabled medical
devices. I strongly support the competency‑based, lifecycle‑aware, and
modular approaches outlined in the document.

I encourage the FDA to:

Adopt modular regulatory units

Require foundation‑model provenance and governance

Implement risk‑tiered continuous monitoring

Promote lifecycle‑native architectures

These principles will help ensure safe, effective, and trustworthy
generative‑AI medical technologies while supporting innovation across the
industry.

PrimordiaOS Technical Positioning Brief
A Lifecycle‑Native Architecture for Competency, Governance, and
Postmarket Monitoring of Generative AI‑Enabled Medical Devices

1. Overview of PrimordiaOS Architecture
PrimordiaOS is a multi‑realm orchestration system designed for autonomous and generative AI
ecosystems. Its architecture is built around modular, claimable units (“realms”) that provide
deterministic state transitions, continuous telemetry, and lifecycle‑wide governance.

Each realm is:

● Isolated for safety and traceability
● Composable for multi‑component AI systems
● Auditable through deterministic claiming
● Lifecycle‑native, supporting premarket, deployment, and postmarket phases

This structure aligns directly with the FDA’s proposed competency‑based and lifecycle‑aware
regulatory framework.

2. Competency Assessment Capabilities
PrimordiaOS includes built‑in mechanisms for competency evaluation across diverse AI
behaviors. These capabilities support the FDA’s call for performance‑based validation.

Key Features
Scenario Generation Realm

● Generates synthetic and real‑world test cases for competency evaluation.

Stress‑Testing Agents

● Automatically probe edge conditions and failure modes.

Deterministic Audit Trails

● Every competency test produces immutable logs for regulatory review.

Lifecycle Re‑Assessment
 ● Competency can be re‑evaluated automatically when models update or drift.

These capabilities allow manufacturers to demonstrate competency in a repeatable, auditable,
and lifecycle‑aware manner.

3. Foundation Model Governance
The FDA highlights foundation models as a major regulatory challenge. PrimordiaOS provides
governance primitives that directly address these concerns.

Governance Features
Model Lineage Tracking Realm

● Captures training data provenance, fine‑tuning history, and model derivation.

Versioned Claiming

● Each model state receives an immutable identifier, enabling precise regulatory
traceability.

Safety Governor Realm

● Enforces constraints across downstream uses of the model.

Drift Detection Agents

● Continuously monitor behavioral changes and trigger re‑evaluation workflows.

These mechanisms support the FDA’s goals for transparency, accountability, and lifecycle
oversight of foundation models.

4. Postmarket Monitoring Infrastructure
PrimordiaOS provides continuous, risk‑tiered monitoring aligned with the FDA’s proposed
postmarket expectations.

Monitoring Features
Multi‑Realm Telemetry Bus

● Collects real‑time performance, safety, and usage data across all components.

Fault‑Tolerant Logging Realm

● Ensures reliable capture of safety‑critical events.
Autonomous Anomaly Detection Agents

● Identify deviations from expected behavior and escalate alerts.

Risk‑Tiered Monitoring Profiles

● Higher‑risk devices receive more intensive oversight automatically.

These capabilities enable manufacturers to meet postmarket monitoring requirements without
building custom infrastructure.

5. Modular Regulatory Alignment
The FDA discussion paper acknowledges the difficulty of regulating multi‑component AI
systems. PrimordiaOS’s realm architecture provides a natural regulatory abstraction.

Regulatory Advantages

● Each realm can be validated independently.
● Updates can be scoped to specific modules.
● Safety governors can be certified as reusable components.
● Telemetry and audit realms provide standardized reporting.

This modularity supports the FDA’s goal of flexible, scalable oversight for complex AI systems.

www.primordialorigin.com